RetinalGenix Technologies Inc. (RTGN)
USD 53.0
(88.0%)
USD 53.0
(88.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -2.08 Million USD | -11.25% |
| 2022 | -1.87 Million USD | -25.37% |
| 2021 | -1.49 Million USD | 9.11% |
| 2020 | -1.64 Million USD | -104.32% |
| 2019 | -805.82 Thousand USD | -55093.15% |
| 2018 | -1460.00 USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -2.14 Million USD | -296.71% |
| 2024 Q2 | -662.67 Thousand USD | 69.11% |
| 2023 FY | -2.08 Million USD | -11.25% |
| 2023 Q4 | -540.68 Thousand USD | 21.24% |
| 2023 Q2 | -351.18 Thousand USD | 31.1% |
| 2023 Q1 | -509.68 Thousand USD | 56.27% |
| 2023 Q3 | -686.46 Thousand USD | -95.47% |
| 2022 Q1 | -373.73 Thousand USD | 8.46% |
| 2022 Q4 | -1.16 Million USD | 53.44% |
| 2022 Q3 | -2.5 Million USD | -599.47% |
| 2022 FY | -1.87 Million USD | -25.37% |
| 2022 Q2 | -357.87 Thousand USD | 4.24% |
| 2021 Q1 | -683.68 Thousand USD | -11.49% |
| 2021 FY | -1.49 Million USD | 9.11% |
| 2021 Q4 | -408.3 Thousand USD | 25.74% |
| 2021 Q3 | -549.84 Thousand USD | 19.58% |
| 2021 Q2 | -683.68 Thousand USD | 0.0% |
| 2020 Q2 | -466.83 Thousand USD | 0.0% |
| 2020 Q4 | -613.19 Thousand USD | -8.13% |
| 2020 FY | -1.64 Million USD | -104.32% |
| 2020 Q3 | -567.09 Thousand USD | -21.48% |
| 2020 Q1 | -466.83 Thousand USD | 0.0% |
| 2019 FY | -805.82 Thousand USD | -55093.15% |
| 2018 FY | -1460.00 USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 85.467% |
| Biotricity, Inc. | -8.82 Million USD | 76.359% |
| Cell MedX Corp. | -313.43 Thousand USD | -565.874% |
| Dynatronics Corporation | -2.27 Million USD | 8.183% |
| Nemaura Medical Inc. | -9.59 Million USD | 78.249% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 80.35% |
| Sonendo, Inc. | -57.74 Million USD | 96.386% |
| Telesis Bio, Inc. | -35.15 Million USD | 94.062% |
| Talis Biomedical Corporation | -66.81 Million USD | 96.876% |
| Viveve Medical, Inc. | -21.55 Million USD | 90.317% |